Guide · Updated November 2026
TrumpRx GLP-1 Prices in 2026: What You’ll Actually Pay
Eli Lilly and Novo Nordisk announced Most Favored Nation pricing agreements covering their GLP-1 drugs with the administration on November 6, 2025. TrumpRx.gov launched on February 5, 2026 as the public price-lookup site for that deal and others like it, with drugs from five manufacturers at launch (AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer) and more promised later. It lists lower cash prices for Ozempic, Wegovy, and Zepbound than most people were paying before. It is not a pharmacy, it is not insurance, and it is not the same program as Medicare's $50 GLP-1 copay. Here's what it actually is and what the current prices are.
TrumpRx isn’t a pharmacy
TrumpRx.gov is a price-lookup and referral site. Depending on the drug, it sends you one of two places. For Ozempic and Wegovy, you accept the offer terms and get a coupon to present at your pharmacy. For Zepbound, the site says Eli Lilly “manages all Zepbound (Tirzepatide) Vial orders through LillyDirect”, so you are handed off to Lilly’s own direct-to-patient site.
The site doesn’t dispense anything itself, and it doesn’t write prescriptions. You still need a valid prescription from a licensed clinician before any of these prices apply to you. If a seller skips that step, that’s a red flag, not a shortcut TrumpRx created.
Comparing telehealth providers instead?
See Provider Comparison →What it actually costs right now
Prices on a referral platform like this move, and more than one figure has been reported since launch. Here is what the TrumpRx.gov drug pages listed on November 4, 2026:
| Drug | Current TrumpRx price | What you need to know |
|---|---|---|
| Wegovy tablet (oral) | $149/month | Lowest dose (1.5 mg). NovoCare lists $199 for 4 mg and $299 for 9 mg and 25 mg. |
| Wegovy injection | $199/month | New patients, first two monthly fills of 0.25 mg and 0.5 mg, through Dec 31, 2026. Then $349/month for 0.25 mg to 2.4 mg and $399/month for Wegovy HD 7.2 mg. |
| Ozempic injection | $199/month | New self-pay patients, first two fills of 0.25 mg or 0.5 mg. Then $349/month for 0.25 mg to 1 mg and $499/month for 2 mg. |
| Zepbound (vial) | $299/month | 2.5 mg only. LillyDirect lists $399 for 5 mg and $449 for 7.5 mg to 15 mg if you refill within 45 days, otherwise $499 to $699. |
These are self-pay cash prices for people using the platform without billing insurance. They are not guaranteed to still be these exact numbers when you check. The February 2026 White House launch fact sheet gave a different kind of figure, an average of $350/month for Ozempic and injectable Wegovy and $346/month for Zepbound, “depending on dosage,” alongside the same “as low as” prices of $199 and $299. The averages blend several doses. The “as low as” figures are starting doses. Treat any number here, including ours, as a starting point and confirm the live listing before you budget around it.
Want the full brand vs. compounded price comparison?
Read the Cheapest GLP-1 Guide →This isn’t the same as Medicare’s $50 copay
TrumpRx cash prices and the Medicare GLP-1 Bridge’s $50/month copay both trace back to the same Most Favored Nation pricing agreements, but they’re not interchangeable and they don’t serve the same people.
The Bridge is the Medicare-specific delivery mechanism for part of that deal. CMS says participating manufacturers supply eligible GLP-1 drugs at a net price of $245 per monthly supply, and an eligible Medicare beneficiary pays a $50 copay outside the normal Part D benefit. It runs July 1, 2026 through December 31, 2027 and covers Foundayo, Wegovy and the Zepbound KwikPen only, not Ozempic and not Zepbound vials. It also requires prior authorization and a qualifying BMI and health condition, listed on Medicare.gov. Our Medicare coverage guide covers Bridge eligibility, and our Medicare negotiated price guide covers the separate statutory price-negotiation program that also touches semaglutide.
TrumpRx’s listed cash prices are for self-pay patients, people buying outside Medicare, Medicaid, and (generally) outside billing their commercial insurance for that specific purchase. The TrumpRx coupon terms say people with government or other insurance must not seek reimbursement for the purchase or count it toward a deductible or out-of-pocket limit. If you’re on Medicare, check Bridge eligibility first.
It may not beat what you could already get
One wrinkle before you treat TrumpRx as the obvious best price. The Wegovy and Ozempic offers on TrumpRx say they have been available since 11/17/2025, about three months before the site launched, and the same prices appear on Novo Nordisk’s own NovoCare self-pay page. Lilly’s LillyDirect shows the same Zepbound prices. For these drugs, the platform is a new place to find an existing manufacturer price rather than a lower one.
That matters for comparison shopping. If you have commercial insurance that covers your GLP-1, a manufacturer savings card advertising as low as $25/month (NovoCare’s Wegovy card caps savings at $100 per month, and terms vary by drug, covered in our savings comparison guide) can beat any of TrumpRx’s cash prices by a wide margin. TrumpRx is a self-pay option, not automatically the cheapest option for everyone.
Bottom Line
TrumpRx.gov is a referral tool, not a pharmacy: it shows a cash price, then routes you to a coupon or to the manufacturer’s own direct platform, and you still need a prescription either way. As of Nov 4, 2026, the lowest listed self-pay prices were $149/month for the Wegovy tablet, $199/month for the first two Wegovy or Ozempic injection fills (rising to $349 after that), and $299/month for the lowest Zepbound vial dose. Check the live site before relying on any figure. It is not the same program as Medicare’s $50 GLP-1 Bridge copay, and it is not automatically cheaper than a manufacturer copay card for someone with covered commercial insurance.
FAQ
Is TrumpRx a pharmacy I can order from directly?
No. It’s a price-lookup and referral site. It shows a cash price and then sends you to a pharmacy coupon or to the manufacturer’s own direct platform, such as LillyDirect or NovoCare, to actually complete the purchase. You still need a prescription.
Do I need Medicare or insurance to use TrumpRx prices?
No, and in most cases you shouldn’t be using it if you’re on Medicare or Medicaid. The listed cash prices are a self-pay option. Medicare beneficiaries get GLP-1 pricing from the same underlying manufacturer agreements through the separate Medicare GLP-1 Bridge program instead.
Is the TrumpRx price always the cheapest option?
Not necessarily. If you have commercial insurance that covers your prescribed GLP-1, a manufacturer copay card can advertise prices as low as $25/month for eligible patients, which beats any TrumpRx cash price. TrumpRx is most relevant if you’re paying cash without using insurance at all.
Why do different sources report different TrumpRx prices for the same drug?
Prices on the platform have moved since its February 2026 launch, and some early coverage cited averages across multiple doses rather than the lowest starting price for a specific dose. Always check the live listing on TrumpRx.gov rather than relying on an older news report.
Related
Guides:
- GLP-1 Medicare Coverage 2026: The Bridge Program Explained
- Medicare’s Negotiated Price for Ozempic and Wegovy (2027)
- GLP-1 Savings: Copay Cards, Self-Pay, and Patient Assistance
- Cheapest Way to Get GLP-1 Medications Online
Compare: All Providers · All Guides
What we checked
This AI-assisted public-source desk check reviewed the TrumpRx.gov drug pages for Wegovy, Ozempic and Zepbound, the White House launch fact sheet, NovoCare and LillyDirect self-pay pages, and CMS and Medicare.gov pages on the Medicare GLP-1 Bridge on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.